The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. [electronic resource]
Producer: 20170516Description: 1-7 p. digitalISSN:- 1090-2430
- 5-alpha Reductase Inhibitors -- therapeutic use
- Adrenergic Agents -- toxicity
- Animals
- Antiparkinson Agents -- adverse effects
- Benserazide -- adverse effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Dyskinesia, Drug-Induced -- drug therapy
- Female
- Finasteride -- therapeutic use
- Functional Laterality -- drug effects
- Levodopa -- adverse effects
- Male
- Oxidopamine -- toxicity
- Parkinson Disease -- drug therapy
- Psychomotor Disorders -- chemically induced
- Rats
- Rats, Sprague-Dawley
- Time Factors
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.